Cargando…

Validation of a modified clinical risk score to predict cancer-specific survival for stage II colon cancer

Many patients with stage II colon cancer will die of their disease despite curative surgery. Therefore, identification of patients at high risk of poor outcome after surgery for stage II colon cancer is desirable. This study aims to validate a clinical risk score to predict cancer-specific survival...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliphant, Raymond, Horgan, Paul G, Morrison, David S, McMillan, Donald C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312121/ https://www.ncbi.nlm.nih.gov/pubmed/25487740 http://dx.doi.org/10.1002/cam4.352

Ejemplares similares

Postoperative Systemic Inflammatory Response, Complication Severity, and Survival Following Surgery for Colorectal Cancer
por: McSorley, Stephen T., et al.
Publicado: (2016)

The Relationship Between Tumor Budding, Tumor Microenvironment, and Survival in Patients with Primary Operable Colorectal Cancer
por: van Wyk, Hester C., et al.
Publicado: (2019)

The Impact of Preoperative Dexamethasone on the Magnitude of the Postoperative Systemic Inflammatory Response and Complications Following Surgery for Colorectal Cancer
por: McSorley, Stephen T., et al.
Publicado: (2017)

Systemic Inflammation and Outcome in 2295 Patients with Stage I–III Colorectal Cancer from Scotland and Norway: First Results from the ScotScan Colorectal Cancer Group
por: Park, James H., et al.
Publicado: (2020)

A new simple morphology‐based risk score is prognostic in stage I/II colon cancers
por: Märkl, Bruno, et al.
Publicado: (2016)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

The Neutrophil-Platelet Score (NPS) Predicts Survival in Primary Operable Colorectal Cancer and a Variety of Common Cancers
por: Watt, David G., et al.
Publicado: (2015)

Clinicopathological Determinants of an Elevated Systemic Inflammatory Response Following Elective Potentially Curative Resection for Colorectal Cancer
por: Watt, David G., et al.
Publicado: (2017)

Perioperative Blood Transfusion is Associated with Postoperative Systemic Inflammatory Response and Poorer Outcomes Following Surgery for Colorectal Cancer
por: McSorley, Stephen T., et al.
Publicado: (2019)

The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer
por: Dreyer, Stephan B., et al.
Publicado: (2016)

Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population‐based analysis
por: Wang, Jiwei, et al.
Publicado: (2019)

The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores
por: Dolan, Ross D, et al.
Publicado: (2018)

Determinants of lymph node count and positivity in patients undergoing surgery for colon cancer
por: Dolan, Ross D., et al.
Publicado: (2018)

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance)
por: Lee, Seohyuk, et al.
Publicado: (2022)

Use of ColonFlag score for prioritisation of endoscopy in colorectal cancer
por: Ayling, Ruth M, et al.
Publicado: (2021)

Staging the Tumor and Staging the Host: Pretreatment Combined Neutrophil Lymphocyte Ratio and Modified Glasgow Prognostic Score Is Associated with Overall Survival in Patients with Esophagogastric Cancers Undergoing Treatment with Curative Intent
por: McSorley, Stephen T., et al.
Publicado: (2020)

Refinement and validation of the IDIOM score for predicting the risk of gastrointestinal cancer in iron deficiency anaemia
por: Almilaji, Orouba, et al.
Publicado: (2020)

Adjuvant chemotherapy in stage II–III operated colon cancer patients from a nontrial cohort in a low colon cancer prevalence country with predominant use of modified CAPOX
por: Ramaswamy, Anant, et al.
Publicado: (2019)

The burden of colon cancer attributable to modifiable factors—The Norwegian Women and Cancer Study
por: Lukic, Marko, et al.
Publicado: (2022)

A nomogram to predict the cancer‐specific survival of stage II–IV Epithelial ovarian cancer after bulking surgery and chemotherapy
por: Zhao, Ling, et al.
Publicado: (2021)

The modified Glasgow prognostic score in prostate cancer: results from a retrospective clinical series of 744 patients
por: Shafique, Kashif, et al.
Publicado: (2013)

An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
por: Proctor, M J, et al.
Publicado: (2011)

A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer
por: Proctor, M J, et al.
Publicado: (2012)

The relationship between the mode of presentation, CT‐derived body composition, systemic inflammatory grade and survival in colon cancer
por: Golder, Allan M., et al.
Publicado: (2022)

Survival of stage II nasopharyngeal carcinoma patients with or without concurrent chemotherapy: A propensity score matching study
por: Liu, Di‐Han, et al.
Publicado: (2019)

Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real‐world data
por: Jongeneel, Gabrielle, et al.
Publicado: (2019)

Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer‐specific survival of patients with kidney cancer
por: Zhou, Yuan, et al.
Publicado: (2020)

Survival in colon and rectal cancers in Finland and Sweden through 50 years
por: Hemminki, Kari, et al.
Publicado: (2021)

A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer
por: Xu, Ke, et al.
Publicado: (2020)

Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score
por: Clive, Amelia O, et al.
Publicado: (2014)

The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer
por: Patel, Meera, et al.
Publicado: (2018)

The impact of socioeconomic status on survival in stage III colon cancer patients: A retrospective cohort study using the SEER census‐tract dataset
por: Dhahri, Amina, et al.
Publicado: (2021)

Longitudinal effects of adjuvant chemotherapy and related neuropathy on health utility in stage II and III colon cancer patients: A prospective cohort study
por: Jongeneel, Gabrielle, et al.
Publicado: (2021)

Development and validation of a nomogram predicting the overall survival of stage IV breast cancer patients
por: Li, Shunrong, et al.
Publicado: (2017)

Colon cancer checks in when bile acids check out: the bile acid–nuclear receptor axis in colon cancer
por: Tang, Qin, et al.
Publicado: (2021)

A clinical risk score to predict 3-, 5- and 10-year survival in patients undergoing surgery for Dukes B colorectal cancer
por: McMillan, D C, et al.
Publicado: (2010)

Interactions of occult tumor spread and surgical technique on overall and disease-free survival in patients operated for stage I and II right-sided colon cancer
por: Banipal, G. S., et al.
Publicado: (2021)

Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I‐II or unresected stage III pancreatic cancer
por: Ma, Sung J., et al.
Publicado: (2019)

Compliance with adjuvant capecitabine in patients with stage II and III colon cancer: comparison of administrative versus medical record data
por: Amlani, Adam, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8g8rm3100fcnqi2m3h8qt921ia